Published 2022 | Version v1
Publication

Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies

Additional details

Identifiers

URL
http://hdl.handle.net/11567/1090620
URN
urn:oai:iris.unige.it:11567/1090620

Origin repository

Origin repository
UNIGE